INCIDENCE OF THROMBOEMBOLIC EVENTS IN THE TOFACITINIB RHEUMATOID ARTHRITIS, PSORIASIS, PSORIATIC ARTHRITIS AND ULCERATIVE COLITIS DEVELOPMENT PROGRAMMES

被引：3
|
作者：
Mease, P. J. [1 ,2 ]
Kremer, J. [3 ]
Cohen, S. [4 ]
Curtis, J. R. [5 ]
Charles-Schoeman, C. [6 ]
Loftus, E. V., Jr. [7 ]
Greenberg, J. [8 ]
Palmetto, N. [7 ]
Kanik, K. S. [10 ]
Graham, D. [10 ]
Wang, C. [10 ]
Biswas, P. [9 ]
Chan, G. [11 ]
DeMasi, R. [11 ]
Valdez, H. [9 ]
Hendrikx, T. [11 ]
Jones, T. V. [11 ]
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Albany Med Coll & Ctr Rheumatol, Albany, NY USA
[4] Metroplex Clin Res Ctr, Dallas, TX USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Mayo Clin, Rochester, MN USA
[8] Corrona LLC, Southborough, MA USA
[9] Pfizer Inc, New York, NY USA
[10] Pfizer Inc, Groton, CT 06340 USA
[11] Pfizer Inc, Collegeville, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.3048
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0243
引用
收藏
页码：983 / 983
页数：1
相关论文
共 50 条
  • [11] Tofacitinib for the treatment of psoriasis and psoriatic arthritis
    Ighani, Arvin
    Georgakopoulos, Jorge R.
    Yeung, Jensen
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2020, 155 (04): : 400 - 410
  • [12] LIVER ENZYME ABNORMALITIES AFTER TOFACITINIB TREATMENT IN PATIENTS WITH HEPATIC STEATOSIS FROM THE RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND PSORIASIS CLINICAL PROGRAMMES
    Soriano, E. R.
    Madariaga, H.
    Castaneda, O.
    Citera, G.
    Schneeberger, E. E.
    Cardiel, M. H.
    Hendrikx, T.
    Graham, D.
    Shi, H.
    Ponce de Leon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 593 - 594
  • [13] Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
    Sandborn, William J.
    Panes, Julian
    Sands, Bruce E.
    Reinisch, Walter
    Su, Chinyu
    Lawendy, Nervin
    Koram, Nana
    Fan, Haiyun
    Jones, Thomas V.
    Modesto, Irene
    Quirk, Daniel
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (10) : 1068 - 1076
  • [14] Incidence of venous thromboembolic events in patients with ulcerative colitis treated with tofacitinib in the ulcerative colitis clinical development programme: An update as of May 2019
    Sandborn, W. J.
    Panes, J.
    Sands, B. E.
    Reinisch, W.
    Modesto, I.
    Su, C.
    Steinwurz, F.
    Lawendy, N.
    Koram, N.
    Kwok, K.
    Jones, T. V.
    Thorpe, A. J.
    Quirk, D.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S498 - S500
  • [15] INCIDENCE OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL DEVELOPMENT PROGRAM: AN UPDATE AS OF MAY 2019
    Sandborn, William J.
    Panes, Julian
    Sands, Bruce E.
    Reinisch, Walter
    Modesto, Irene
    Su, Chinyu
    Steinwurz, Flavio
    Lawendy, Nervin
    Koram, Nana
    Kwok, Kenneth
    Jones, Thomas V.
    Thorpe, Andrew J.
    Quirk, Daniel
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S144 - S144
  • [16] Malignancy Events in the Filgotinib Rheumatoid Arthritis and Ulcerative Colitis Clinical Development Programs
    Mariette, Xavier
    Aspeslagh, Sandrine
    Moriggl, Richard
    Rajendran, Vijay
    Rudolph, Christine
    Van Hoek, Paul
    Verbruggen, Nadia
    Watson, Christopher
    Borchmann, Sven
    Stallmach, Andreas
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 528 - 531
  • [17] The Prevalence, Incidence and Management of Hypertension, Diabetes and Hyperlipidemia in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis
    Jafri, Kashif
    Bartels, Christie M.
    Shin, Daniel
    Ogdie-Beatty, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [18] COMORBIDITIES IN PSORIATIC ARTHRITIS: COMPARISON WITH RHEUMATOID ARTHRITIS AND PSORIASIS
    Nas, K.
    Karkucak, M.
    Durmus, B.
    Karatay, S.
    Capkin, E.
    Kaya, A.
    Ucmak, D.
    Akar, Z. A.
    Cevik, R.
    Ozgocmen, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 812 - 812
  • [19] Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn's disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis
    Bolge, Susan C.
    Eldridge, Helen M.
    Lofland, Jennifer H.
    Ravin, Caitlin
    Hart, Philip J.
    Ingham, Michael P.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 661 - 669
  • [20] Mendelian randomization analysis of psoriasis and psoriatic arthritis associated with risks of ulcerative colitis
    Pan, Jing
    Lv, Yanwei
    Wang, Lingyan
    Chang, Xiaodan
    Zhao, Kaiping
    Liu, Xiao
    SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (07)
12345